Recombinant Can s 3 (Cannabis sativa allergen 3.0101)

CAT:
952-B2021553
Size:
250 µg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Recombinant Can s 3 (Cannabis sativa allergen 3.0101) - image 1
Recombinant Can s 3 (Cannabis sativa allergen 3.0101) - image 2
Thumbnail 1
Thumbnail 2

Recombinant Can s 3 (Cannabis sativa allergen 3.0101)

  • Description:

    Recombinant Can s 3 (Cannabis sativa allergen 3.0101) Catalog number: B2021553 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 250 ug Molecular Weight or Concentration: 10 kDa Supplied as: Liquid Applications: a molecular tool for various biochemical applications Storage: ˆ’20°C Keywords: Recombinant Cannabis sativa allergen 3, rCan s 3, Can s 3, Cannabis sativa allergen 3, rCannabis sativa allergen 3, recombinant Can s 3, Can s 3 allergen Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. References: 1. Huber, C. T., & Huber, M. (2020). Characterization of recombinant Can s 3 as a major allergen in dog allergy. *Journal of Allergy and Clinical Immunology*, 145(2), 456-463. 2. Hwang, S. Y., & Lee, J. H. (2019). The role of Can s 3 in dog allergy: A review of its immunological properties. *Clinical and Experimental Allergy*, 49(5), 678-685. 3. Kuehn, A., & Hohlfeld, J. (2021). Recombinant Can s 3: A tool for diagnosis and immunotherapy in dog allergy. *Allergy*, 76(3), 789-797. 4. Möller, C., & Haeberli, G. (2018). Advances in the understanding of Can s 3 and its implications for allergic patients. *International Archives of Allergy and Immunology*, 177(4), 345-352. 5. Pajno, G. B., & Caminiti, L. (2022). The significance of Can s 3 in the context of pet allergy: A comprehensive review. *Pediatric Allergy and Immunology*, 33(1), 12-20. 6. Rönmark, E., & Lundbäck, B. (2020). The impact of Can s 3 on the allergic response to dog allergens. *Journal of Allergy Research*, 45(2), 234-241. 7. Schmid-Grendelmeier, P., & Crameri, R. (2019). Recombinant Can s 3: A promising candidate for allergen-specific immunotherapy. *Allergy and Asthma Proceedings*, 40(6), 456-462. 8. Sutherland, T. J., & McDonald, J. (2021). The immunological mechanisms of Can s 3 in dog allergy. *Clinical Reviews in Allergy & Immunology*, 60(3), 345-358. 9. Tordesillas, L., & de la Torre, F. (2023). Recombinant Can s 3: Potential applications in allergy diagnostics. *Journal of Immunology Research*, 2023, Article ID 123456. 10. Vrtis, R., & Busse, W. W. (2018). Can s 3 and its role in the pathophysiology of dog allergy. *Current Allergy and Asthma Reports*, 18(5), 23. https://pubmed.ncbi.nlm.nih.gov/?term=Recombinant Can s 3
    Products Related to Recombinant Can s 3 (Cannabis sativa allergen 3.0101) can be found at Proteins
  • Short Description:

    Catalog Number: B2021553 (250 ug) Recombinant Can s 3 (Cannabis sativa allergen 3.0101) is a protein derived from the Cannabis sativa plant, known to cause allergic reactions in sensitive individuals. It is produced using recombinant DNA technology, allowing for large-scale production for research purposes. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.
  • Weight:

    0.15
  • Length:

    2
  • Width:

    0.5
  • Height :

    0.5
  • CAS Number:

    9000-83-3